Related references
Note: Only part of the references are listed.Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Harry Ridgway et al.
VIRUSES-BASEL (2023)
Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome
Mohnad Abdalla et al.
JOURNAL OF MEDICAL VIROLOGY (2023)
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association
Connie W. Tsao et al.
CIRCULATION (2022)
A global picture: therapeutic perspectives for COVID-19
Vivek P. Chavda et al.
IMMUNOTHERAPY (2022)
The T cell immune response against SARS-CoV-2
Paul Moss
NATURE IMMUNOLOGY (2022)
The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It
Jonaid Ahmad Malik et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2022)
The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review
Monika Gudowska-Sawczuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
Ilaria Caputo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
Qiuping Xie et al.
ANNALS OF PALLIATIVE MEDICINE (2022)
Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19
Moudhi Almutlaq et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System
Graham J. Moore et al.
MOLECULES (2022)
Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research
Namin Wei et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
John M. Matsoukas et al.
BIOMEDICINES (2022)
Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
Weronika Frak et al.
BIOMEDICINES (2022)
Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
Rafael L. Camargo et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Alamandine alleviated heart failure and fibrosis in myocardial infarction mice
Kun Zhao et al.
BIOLOGY DIRECT (2022)
Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling
Xin-Sen Chen et al.
PHARMACOLOGICAL RESEARCH (2022)
Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
Dengyuan Liu et al.
CELL DISCOVERY (2022)
Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2
Harry Ridgway et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry
Fabio Angeli et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2022)
Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
Amirhossein Hessami et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)
Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
Jing Ma et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells
Manel Essaidi-Laziosi et al.
LANCET MICROBE (2021)
A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17
Eamonn F. Healy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality?
Martin R. Salazar
JOURNAL OF CLINICAL HYPERTENSION (2021)
Neutrophils mediate Th17 promotion in COVID-19 patients
Zuzana Parackova et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
John Matsoukas et al.
MOLECULES (2021)
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
Maedeh Amini et al.
BMC PUBLIC HEALTH (2021)
Alamandine via MrgD receptor attenuates pulmonary fibrosis via NOX4 and autophagy pathway
Qingxia Liu et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2021)
Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment
Laura Kate Gadanec et al.
FUTURE MICROBIOLOGY (2021)
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease
Sebastian Cremer et al.
PLOS ONE (2021)
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
Andre Santa Cruz et al.
FRONTIERS IN IMMUNOLOGY (2021)
COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies
Ashraf Roshdy et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity
Maryam Eskandari Mehrabadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
COVID-19 and Cardiovascular Disease From Bench to Bedside
Mina K. Chung et al.
CIRCULATION RESEARCH (2021)
Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats
Ava Soltani Hekmat et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2021)
Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
Rodolfo Pedro Rothlin et al.
FRONTIERS IN PHARMACOLOGY (2021)
COVID-19 and Hypertension: The What, the Why, and the How
Shah-Abas Muhamad et al.
FRONTIERS IN PHYSIOLOGY (2021)
The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome
Anna Kosyreva et al.
FRONTIERS IN IMMUNOLOGY (2021)
Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
Antonia Anna Lukito et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells
Gabriel Augusto Pires de Souza et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
M. Ekholm et al.
FRONTIERS IN PHARMACOLOGY (2021)
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
Kanika Verma et al.
FRONTIERS IN PHARMACOLOGY (2021)
Protective effect of alamandine on doxorubicin-induced nephrotoxicity in rats
Ava Soltani Hekmat et al.
BMC PHARMACOLOGY & TOXICOLOGY (2021)
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
Ikram Omar Osman et al.
FRONTIERS IN IMMUNOLOGY (2021)
ACE2, the Counter-Regulatory Renin-Angiotensin System Axis and COVID-19 Severity
Filippos Triposkiadis et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19
Graham J. Moore et al.
BIOMOLECULES (2021)
Assessment of Alamandine in Pulmonary Fibrosis and Respiratory Mechanics in Rodents
Renata Streck Fernandes et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2021)
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
Louisa Ruhl et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
Mariano Duarte et al.
ECLINICALMEDICINE (2021)
Counter-regulatory renin-angiotensin system in cardiovascular disease
Maria Paz Ocaranza et al.
NATURE REVIEWS CARDIOLOGY (2020)
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
David Gurwitz
DRUG DEVELOPMENT RESEARCH (2020)
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
Yingxia Liu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Peng Zhang et al.
CIRCULATION RESEARCH (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19
Rodolfo Pedro Rothlin et al.
DRUG DEVELOPMENT RESEARCH (2020)
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
Juan Simon Rico-Mesa et al.
CURRENT CARDIOLOGY REPORTS (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication
Xiaocong Pang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Alice Huertas et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Julia Hippisley-Cox et al.
HEART (2020)
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
Giovanni A. Rossi et al.
INFECTION (2020)
Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology
Amanda St Paul et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in
Fang Liu et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19
Abbas Soleimani et al.
AMERICAN JOURNAL OF HYPERTENSION (2020)
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
Francois Alhenc-Gelas et al.
KIDNEY INTERNATIONAL (2020)
Could DIZE be the answer to COVID-19?
Tawar Qaradakhi et al.
MATURITAS (2020)
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
Bastien Genet et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
Jinsung Yang et al.
NATURE COMMUNICATIONS (2020)
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome
Alberto Palazzuoli et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
T Cells in Autoimmunity-Associated Cardiovascular Diseases
Daniella Muallem Schwartz et al.
FRONTIERS IN IMMUNOLOGY (2020)
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
Larissa Braga Costa et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Oxidative Stress in Cardiovascular Diseases
Emilie Dubois-Deruy et al.
ANTIOXIDANTS (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells
Tapas Patra et al.
PLOS PATHOGENS (2020)
Signal Transduction Profiling of Angiotensin II Type 1 Receptor With Mutations Associated to Atrial Fibrillation in Humans
Sarah C. Simoes et al.
FRONTIERS IN PHARMACOLOGY (2020)
Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy
Chang Youn Lee et al.
MOLECULES (2020)
Candesartan could ameliorate the COVID-19 cytokine storm
Abdel G. Elkahloun et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Inflammation and cardiovascular disease: From mechanisms to therapeutics
Abdulhamied Alfaddagh et al.
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer
Mohammad Nurul Amin et al.
SAGE OPEN MEDICINE (2020)
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
Alberto Zangrillo et al.
CRITICAL CARE (2020)
Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients
Zhiyong Wu et al.
CRITICAL CARE (2020)
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo et al.
INFLAMMATION AND REGENERATION (2020)
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
Juan Meng et al.
EMERGING MICROBES & INFECTIONS (2020)
Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice
Fernando Pedro de Souza-Neto et al.
CLINICAL SCIENCE (2019)
Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study
Raju Reddy et al.
PLOS ONE (2019)
Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill
Laurent Bitker et al.
CRITICAL CARE CLINICS (2019)
Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
Thomas Senoner et al.
NUTRIENTS (2019)
Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice
Aline Cristina Oliveira et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
Occurrence of the potent mutagens 2-nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
Aldenor G. Santos et al.
SCIENTIFIC REPORTS (2019)
Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells
Sang-Min Kim et al.
BMB REPORTS (2019)
Overview of the IL-1 family in innate inflammation and acquired immunity
Charles A. Dinarello
IMMUNOLOGICAL REVIEWS (2018)
The Conducted Vasomotor Response: Function, Biophysical Basis, and Pharmacological Control
Donald G. Welsh et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Renin-Angiotensin System and Cardiovascular Functions
Chia-Hua Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Vascular smooth muscle contraction in hypertension
Rhian M. Touyz et al.
CARDIOVASCULAR RESEARCH (2018)
Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders
Ewa Szczepanska-Sadowska et al.
CURRENT HYPERTENSION REPORTS (2018)
Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases
Wan Shun Daniel Tan et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion
Qing-Guang Wang et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2018)
Vascular Oxidative Stress: Impact and Therapeutic Approaches
Cristina M. Sena et al.
FRONTIERS IN PHYSIOLOGY (2018)
Involvement of vascular peroxidase 1 in angiotensin II-induced hypertrophy of H9c2 cells
Wei Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2017)
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism
Takanobu Takezako et al.
PHARMACOLOGICAL RESEARCH (2017)
AT1 receptor signaling pathways in the cardiovascular system
Tatsuo Kawai et al.
PHARMACOLOGICAL RESEARCH (2017)
Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia
Yan Fei Qi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells
Ying Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Activation of Human T Cells in Hypertension Studies of Humanized Mice and Hypertensive Humans
Hana A. Itani et al.
HYPERTENSION (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Angiotensin (1-7) and Alamandine: Similarities and differences
Tawar Qaradakhi et al.
PHARMACOLOGICAL RESEARCH (2016)
Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8+ T cells
Joao Luiz Silva-Filho et al.
SCIENTIFIC REPORTS (2016)
The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases
Hazel Mae A. Abraham et al.
DRUG SAFETY (2015)
Angiotensin II, From Vasoconstrictor to Growth Factor A Paradigm Shift
Sasa Vukelic et al.
CIRCULATION RESEARCH (2014)
Alamandine: a new member of the angiotensin family
Daniel C. Villela et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
A Possible Change Process of Inflammatory Cytokines in the Prolonged Chronic Stress and Its Ultimate Implications for Health
Rui Tian et al.
SCIENTIFIC WORLD JOURNAL (2014)
Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation
Jessica R. Gomolak et al.
FRONTIERS IN PHYSIOLOGY (2014)
Boerhaavia diffusa L. attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-κβ and transforming growth factor β1
A. Prathapan et al.
BRITISH JOURNAL OF NUTRITION (2013)
Discovery and Characterization of Alamandine A Novel Component of the Renin-Angiotensin System
Roberto Queiroga Lautner et al.
CIRCULATION RESEARCH (2013)
Rational design, efficient syntheses and biological evaluation of N,N′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers
George Agelis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials
Hisato Takagi et al.
HYPERTENSION RESEARCH (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Martin C. Michel et al.
PHARMACOLOGICAL REVIEWS (2013)
Inflammatory Cytokines in Heart Failure: Mediators and Markers
Lars Gullestad et al.
CARDIOLOGY (2012)
Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells
Ryousuke Satou et al.
FASEB JOURNAL (2012)
Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway
Alia Shatanawi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Angiotensin II receptors and drug discovery in cardiovascular disease
Chiranjib Dasgupta et al.
DRUG DISCOVERY TODAY (2011)
Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety
Addison A. Taylor et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Role of Angiotensin II Type 1 Receptor in Angiotensin II-Induced Cytokine Production in Macrophages
Feng Guo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor
Hui Yang et al.
PEPTIDES (2011)
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
Helmy M. Siragy
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction
Yong Wang et al.
CIRCULATION-HEART FAILURE (2010)
Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells
Nina Lane et al.
CLINICAL SCIENCE (2010)
Triple Therapy With Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide in Adult Patients With Hypertension: The TRINITY Multicenter, Randomized, Double-Blind, 12-Week, Parallel-Group Study
Suzanne Oparil et al.
CLINICAL THERAPEUTICS (2010)
The Role of the Transcription Factor CREB in Immune Function
Andy Y. Wen et al.
JOURNAL OF IMMUNOLOGY (2010)
Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters
Keiji Kuba et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
Julius Benicky et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity
Federica Sallusto et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II-Induced Muscle Wasting
Liping Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+MYPT1 Expression
Erhan Ararat et al.
PLOS ONE (2009)
Cardiac fibroblasts: At the heart of myocardial remodeling
Karen E. Porter et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway
Vijay Koka et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy
Minoru Satoh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells
Dongli Yang et al.
EXPERIMENTAL EYE RESEARCH (2007)
The regulation of the inflammatory response through nuclear factor-kappa B pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases
Marta Ruiz-Ortega et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2007)
Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes
Peter H. Sugden et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Angiotensin-converting enzyme 2 in lung diseases
Keiji Kuba et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Angiotensin II Ca2+ signaling in rat afferent arterioles:: stimulation of cyclic ADP ribose and IP3 pathways
SK Fellner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Myocardial infarction increases ACE2 expression in rat and humans
LM Burrell et al.
EUROPEAN HEART JOURNAL (2005)
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors
Y Ishiyama et al.
HYPERTENSION (2004)
Angiotensin II regulation of collagen type I expression in cardiac fibroblasts -: Modulation by PPAR-γ ligand pioglitazone
K Chen et al.
HYPERTENSION (2004)
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension
HS Ju et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Involvement of nuclear factor-κB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy
S Hirotani et al.
CIRCULATION (2002)
Role of the renin-angiotensin system in vascular diseases -: Expanding the field
M Ruiz-Ortega et al.
HYPERTENSION (2001)
Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells
D Chansel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)